Effect of ACE inhibitors in diabetic and nondiabetic chronic renal disease: a systematic overview of randomized placebo-controlled trials (Q73598695)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10739792%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

meta-analysis

0 references

title

Effect of ACE inhibitors in diabetic and nondiabetic chronic renal disease: a systematic overview of randomized placebo-controlled trials (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10739792%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

chronic renal disease

1 reference

A V Kshirsagar

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10739792%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

M S Joy

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10739792%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

S L Hogan

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10739792%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

R J Falk

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10739792%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

R E Colindres

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10739792%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

publication date

1 April 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10739792%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Kidney Diseases

5 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10739792%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10739792%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10739792%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

695-707

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10739792%20AND%20SRC:MED&resulttype=core&format=json

Angiotensin II type 2 receptor mediates programmed cell death

5 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970018-7

7 January 2021

Angiotensin II activates Na+-H+ exchange and stimulates growth in cultured vascular smooth muscle cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970018-7

7 January 2021

Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970018-7

7 January 2021

Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970018-7

7 January 2021

Angiotensin-converting enzyme inhibition in nondiabetic progressive renal insufficiency: a controlled double-blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970018-7

7 January 2021

Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970018-7

7 January 2021

Comparative study of the effect of ACE-inhibitors and other antihypertensive agents on proteinuria in diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970018-7

7 January 2021

Effect of antihypertensive therapy on the kidney in patients with diabetes: a meta-regression analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970018-7

7 January 2021

Long-term effects of antihypertensive agents on proteinuria and renal function

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970018-7

7 January 2021

Effect of angiotensin-converting enzyme inhibitors on the progression of nondiabetic renal disease: a meta-analysis of randomized trials. Angiotensin-Converting-Enzyme Inhibition and Progressive Renal Disease Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970018-7

7 January 2021

Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970018-7

7 January 2021

Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970018-7

7 January 2021

The beneficial effect of angiotensin-converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria. North American Microalbuminuria Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970018-7

7 January 2021

A randomized, double-blind, placebo-controlled trial to evaluate the effect of enalapril in patients with clinical diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970018-7

7 January 2021

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970018-7

7 January 2021

Effects of captopril treatment versus placebo on renal function in type 2 diabetic patients with microalbuminuria: a long-term study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970018-7

7 January 2021

ACE inhibitor mediated reductions in renal size and microalbuminuria in normotensive, diabetic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970018-7

7 January 2021

Effective postponement of diabetic nephropathy with enalapril in normotensive type 2 diabetic patients with microalbuminuria.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970018-7

7 January 2021

Effects of lisinopril and nifedipine on the progression to overt albuminuria in IDDM patients with incipient nephropathy and normal blood pressure. The Italian Microalbuminuria Study Group in IDDM.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970018-7

7 January 2021

A comparison of the effect of ramipril, felodipine and placebo on glomerular filtration rate, albuminuria, blood pressure and vasoactive hormones in chronic glomerulonephritis. A randomized, prospective, double-blind, placebo-controlled study over t

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970018-7

7 January 2021

Effects of perindopril on renal histomorphometry in diabetic subjects with microalbuminuria: a 3-year placebo-controlled biopsy study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970018-7

7 January 2021

The statistical basis of meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970018-7

7 January 2021

Meta-analysis in clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970018-7

7 January 2021

The relation between funding by the National Institutes of Health and the burden of disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970018-7

7 January 2021

Studying the causes of kidney disease in humans: a review of methodologic obstacles and possible solutions

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970018-7

7 January 2021

Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970018-7

7 January 2021

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970018-7

7 January 2021

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970018-7

7 January 2021

Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970018-7

7 January 2021

The Effects of Dietary Protein Restriction and Blood-Pressure Control on the Progression of Chronic Renal Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970018-7

7 January 2021

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970018-7

7 January 2021

10.1016/S0272-6386(00)70018-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10739792%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference